On the public citation graph
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
0 signed · 352 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaoncol.2015.3239openalex-snapshot
Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2016.1061openalex-snapshot
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
inferredcites →https://doi.org/10.1001/jamaoncol.2016.3824openalex-snapshot
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy
inferredcites →https://doi.org/10.1001/jamaoncol.2017.2085openalex-snapshot
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2017.2140openalex-snapshot
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3openalex-snapshot
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
inferredcites →https://doi.org/10.1002/bjs.10127openalex-snapshot
Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer
inferredcites →https://doi.org/10.1002/ijc.10915openalex-snapshot
Prognostic value of tumor‐infiltrating dendritic cells expressing CD83 in human breast carcinomas
inferredcites →https://doi.org/10.1007/s10549-012-2245-8openalex-snapshot
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients
inferredcites →https://doi.org/10.1007/s10549-017-4499-7openalex-snapshot
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
inferredcites →https://doi.org/10.1007/s10549-020-05771-7openalex-snapshot
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
inferredcites →https://doi.org/10.1007/s12282-016-0698-zopenalex-snapshot
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
inferredcites →https://doi.org/10.1016/j.annonc.2020.01.072openalex-snapshot
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
inferredcites →https://doi.org/10.1016/j.annonc.2020.08.2241openalex-snapshot
LBA13 Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial
inferredcites →https://doi.org/10.1016/j.annonc.2020.08.2243openalex-snapshot
LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
inferredcites →https://doi.org/10.1016/j.annonc.2020.08.281openalex-snapshot
159O Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the PARADIGM study group
inferredcites →https://doi.org/10.1016/j.annonc.2020.08.284openalex-snapshot
162MO Neoadjuvant chemotherapy and immunotherapy in Luminal B BC: Results of the phase II GIADA trial
inferredcites →https://doi.org/10.1016/j.annonc.2021.05.801openalex-snapshot
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
inferredcites →https://doi.org/10.1016/j.annonc.2022.02.004openalex-snapshot
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
inferredcites →https://doi.org/10.1016/j.breast.2016.07.015openalex-snapshot
The genomic landscape of breast cancer and its interaction with host immunity
inferredcites →https://doi.org/10.1016/j.clbc.2017.11.001openalex-snapshot
Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy
inferredcites →https://doi.org/10.1016/j.ctrv.2012.04.011openalex-snapshot
The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer
inferredcites →https://doi.org/10.1016/j.ctrv.2016.03.011openalex-snapshot
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?
inferredcites →https://doi.org/10.1016/j.ctrv.2017.04.005openalex-snapshot
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
inferredcites →https://doi.org/10.1016/j.ctrv.2018.08.010openalex-snapshot
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
inferredcites →https://doi.org/10.1016/j.prp.2020.153085openalex-snapshot
The role of tumor-associated macrophages in the development, metastasis and treatment of breast cancer
inferredcites →https://doi.org/10.1016/j.semcancer.2017.10.003openalex-snapshot
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
inferredcites →https://doi.org/10.1016/j.semcancer.2018.07.001openalex-snapshot
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
inferredcites →https://doi.org/10.1016/s0140-6736(20)31953-xopenalex-snapshot
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
inferredcites →https://doi.org/10.1016/s0140-6736(20)32531-9openalex-snapshot
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
inferredcites →https://doi.org/10.1016/s1470-2045(13)70477-7openalex-snapshot
The immune system and response to HER2-targeted treatment in breast cancer
inferredcites →https://doi.org/10.1016/s1470-2045(16)30631-3openalex-snapshot
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
inferredcites →https://doi.org/10.1016/s1470-2045(17)30904-xopenalex-snapshot
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
inferredcites →https://doi.org/10.1016/s1470-2045(18)30812-xopenalex-snapshot
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(20)30450-2openalex-snapshot
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
inferredcites →https://doi.org/10.1016/s1470-2045(20)30465-4openalex-snapshot
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
inferredcites →https://doi.org/10.1038/bjc.2013.634openalex-snapshot
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
inferredcites →https://doi.org/10.1038/modpathol.2016.109openalex-snapshot
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
inferredcites →https://doi.org/10.1038/s41591-018-0078-7openalex-snapshot
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
inferredcites →https://doi.org/10.1056/nejmoa1809615openalex-snapshot
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1910549openalex-snapshot
Pembrolizumab for Early Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1056/nejmp1900079openalex-snapshot
Residual Disease after Neoadjuvant Therapy — Developing Drugs for High-Risk Early Breast Cancer
inferredcites →https://doi.org/10.1080/07357900802098165openalex-snapshot
Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
inferredcites →https://doi.org/10.1080/2162402x.2018.1466017openalex-snapshot
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
inferredcites →https://doi.org/10.1084/jem.190.10.1417openalex-snapshot
In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas
inferredcites →https://doi.org/10.1093/annonc/mdt556openalex-snapshot
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
inferredcites →https://doi.org/10.1093/annonc/mdu112openalex-snapshot
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
inferredcites →https://doi.org/10.1093/annonc/mdu191openalex-snapshot
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
inferredcites →https://doi.org/10.1093/annonc/mdu450openalex-snapshot
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
inferredcites →https://doi.org/10.1093/annonc/mdv239openalex-snapshot
Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
inferredcites →https://doi.org/10.1093/annonc/mdw262openalex-snapshot
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
inferredcites →https://doi.org/10.1093/annonc/mdw393.07openalex-snapshot
Tumor infiltrating lymphocytes and tertiary lymphoid structures in paired primary tumors and metastases from breast cancer patients
inferredcites →https://doi.org/10.1093/annonc/mdx138.004openalex-snapshot
Tumor infiltrating lymphocytes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of published randomized clinical trials
inferredcites →https://doi.org/10.1093/annonc/mdx362.061openalex-snapshot
IMpassion031: A phase III study comparing neoadjuvant atezolizumab (atezo) vs placebo in combination with anthracycline/nab-paclitaxel (nab-pac)–based chemotherapy in early triple-negative breast cancer (eTNBC)
inferredcites →https://doi.org/10.1093/annonc/mdx440.005openalex-snapshot
Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086
inferredcites →https://doi.org/10.1093/annonc/mdx647openalex-snapshot
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
inferredcites →https://doi.org/10.1093/annonc/mdy399openalex-snapshot
Immunological differences between primary and metastatic breast cancer
inferredcites →https://doi.org/10.1093/annonc/mdy414openalex-snapshot
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
inferredcites →https://doi.org/10.1093/annonc/mdy517openalex-snapshot
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
inferredcites →https://doi.org/10.1093/annonc/mdz007openalex-snapshot
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
inferredcites →https://doi.org/10.1093/annonc/mdz158openalex-snapshot
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
inferredcites →https://doi.org/10.1093/annonc/mdz201openalex-snapshot
The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine
inferredcites →https://doi.org/10.1093/annonc/mdz235openalex-snapshot
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
inferredcites →https://doi.org/10.1093/annonc/mdz242openalex-snapshot
Overall survival (OS) in KATE2, a phase II study of programmed death ligand 1 (PD-L1) inhibitor atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC)
inferredcites →https://doi.org/10.1093/annonc/mdz394.009openalex-snapshot
Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130
inferredcites →https://doi.org/10.1093/annonc/mdz394.010openalex-snapshot
KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
inferredcites →https://doi.org/10.1093/annonc/mdz395openalex-snapshot
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
inferredcites →https://doi.org/10.1093/jnci/dju152openalex-snapshot
Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1093/jnci/djw192openalex-snapshot
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
inferredcites →https://doi.org/10.1093/jnci/djz032openalex-snapshot
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1097/cco.0000000000000131openalex-snapshot
Oncogene addiction and immunity
inferredcites →https://doi.org/10.1111/cas.14230openalex-snapshot
Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
inferredcites →https://doi.org/10.1111/his.12607openalex-snapshot
High numbers of macrophages, especially M2‐like ( CD 163‐positive), correlate with hyaluronan accumulation and poor outcome in breast cancer
inferredcites →https://doi.org/10.1136/esmoopen-2017-000305openalex-snapshot
Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
inferredcites →https://doi.org/10.1136/jclinpath-2011-200355openalex-snapshot
Tumour-infiltrating macrophages and clinical outcome in breast cancer
inferredcites →https://doi.org/10.1155/2017/1049023openalex-snapshot
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-0684openalex-snapshot
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-4491openalex-snapshot
Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-0239openalex-snapshot
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-3368openalex-snapshot
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-1622openalex-snapshot
Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-16-1513openalex-snapshot
Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation?
inferredcites →https://doi.org/10.1158/1078-0432.ccr-19-1402openalex-snapshot
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-20-1731openalex-snapshot
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
inferredcites →https://doi.org/10.1158/1078-0432.ccr-21-2260openalex-snapshot
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
inferredcites →https://doi.org/10.1158/1538-7445.sabcs18-gs1-04openalex-snapshot
Abstract GS1-04: IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, phase III study of atezolizumab + nab-paclitaxel in patients with treatment-naïve, locally advanced or metastatic triple-negative breast cancer
inferredcites →https://doi.org/10.1158/1538-7445.sabcs19-gs3-04openalex-snapshot
Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
inferredcites →https://doi.org/10.1158/1538-7445.sabcs19-pd5-03openalex-snapshot
Abstract PD5-03: Relationship between tumor-infiltrating lymphocytes (TILs) and outcomes in the KEYNOTE-119 study of pembrolizumab vs chemotherapy for previously treated metastatic triple-negative breast cancer (mTNBC)
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000504055openalex-snapshot
The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting
inferredcites →https://doi.org/10.1172/jci96313openalex-snapshot
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
inferredcites →https://doi.org/10.1186/1479-5876-11-145openalex-snapshot
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
inferredcites →https://doi.org/10.1186/bcr3072openalex-snapshot
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
inferredcites →https://doi.org/10.1186/bcr3148openalex-snapshot
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
inferredcites →https://doi.org/10.1186/s12967-015-0535-8openalex-snapshot
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
inferredcites →https://doi.org/10.1186/s13058-014-0432-8openalex-snapshot
Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration
inferredcites →https://doi.org/10.1186/s13058-014-0488-5openalex-snapshot
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
inferredcites →https://doi.org/10.1186/s13058-015-0621-0openalex-snapshot
Human breast cancer cells educate macrophages toward the M2 activation status
inferredcites →https://doi.org/10.1186/s13058-016-0783-4openalex-snapshot
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
inferredcites →https://doi.org/10.1186/s13058-018-0942-xopenalex-snapshot
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population
inferredcites →https://doi.org/10.1186/s13058-018-1003-1openalex-snapshot
Immune characterization of breast cancer metastases: prognostic implications
inferredcites →https://doi.org/10.1186/s13058-018-1076-xopenalex-snapshot
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
inferredcites →https://doi.org/10.1186/s13058-019-1176-2openalex-snapshot
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes
inferredcites →https://doi.org/10.1186/s40425-019-0548-6openalex-snapshot
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
inferredcites →https://doi.org/10.1200/jco.18.01010openalex-snapshot
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
inferredcites →https://doi.org/10.1200/jco.2006.05.9584openalex-snapshot
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse
inferredcites →https://doi.org/10.1200/jco.2009.23.7370openalex-snapshot
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2010.30.5037openalex-snapshot
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2011.41.0902openalex-snapshot
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
inferredcites →https://doi.org/10.1200/jco.2013.31.15_suppl.tps1142openalex-snapshot
MERiDiAN: A phase III, randomized, double-blind study of the efficacy, safety, and associated biomarkers of bevacizumab plus paclitaxel compared with paclitaxel plus placebo, as first-line treatment of patients with HER2-negative metastatic breast cancer.
inferredcites →https://doi.org/10.1200/jco.2014.57.6298openalex-snapshot
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial
inferredcites →https://doi.org/10.1200/jco.2017.35.15_suppl.1088openalex-snapshot
Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B.
inferredcites →https://doi.org/10.1200/jco.2019.37.15_suppl.1012openalex-snapshot
Genomic correlates of response to adjuvant trastuzumab (H) and pertuzumab (P) in HER2+ breast cancer (BC): Biomarker analysis of the APHINITY trial.
inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.1000openalex-snapshot
KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.
inferredcites →https://doi.org/10.1371/journal.pmed.1002194openalex-snapshot
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
inferredcites →https://doi.org/10.1371/journal.pone.0076147openalex-snapshot
High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer
inferredcites →https://doi.org/10.1371/journal.pone.0125728openalex-snapshot
Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer
inferredcites →https://doi.org/10.1634/theoncologist.2019-0197openalex-snapshot
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
inferredcites →https://doi.org/10.18632/oncotarget.27081openalex-snapshot
Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
inferredcites →https://doi.org/10.2147/ott.s61838openalex-snapshot
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
inferredcites →https://doi.org/10.21873/invivo.11415openalex-snapshot
CD11c-Positive Dendritic Cells in Triple-negative Breast Cancer
inferredcites →https://doi.org/10.3389/fimmu.2017.01544openalex-snapshot
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
inferredcites →https://doi.org/10.3892/ol.2017.6144openalex-snapshot
Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy
inferredcites →https://doi.org/10.4048/jbc.2013.16.1.32openalex-snapshot
Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4985156openalex-extracted
Machine Learning-Derived Prognostic Signature Based on Genes-Associated with 19 Types of Programmed Cell Death in Lung Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1001/jamaoncol.2024.6872openalex-snapshot
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.1002/advs.202508358openalex-snapshot
Multiscale Cell–Cell Interactive Spatial Transcriptomics Analysis
inferred← citeshttps://doi.org/10.1002/cam4.72037openalex-snapshot
A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor‐Associated Immune Cell Infiltration Abundance
inferred← citeshttps://doi.org/10.1002/cnr2.70600openalex-snapshot
Ultrasound and Clinicopathological Features‐Based Machine Learning Model for Predicting Neoadjuvant Therapy Efficacy in Breast Cancer
inferred← citeshttps://doi.org/10.1002/ctd2.199openalex-snapshot
Specificity and function of T cell subset identities using single‐cell sequencing
inferred← citeshttps://doi.org/10.1002/jum.16058openalex-snapshot
Evaluating Tumor‐Infiltrating Lymphocytes in Breast Cancer
inferred← citeshttps://doi.org/10.1002/mco2.551openalex-snapshot
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
inferred← citeshttps://doi.org/10.1002/path.6061openalex-snapshot
Artificial intelligence‐based digital scores of stromal tumour‐infiltrating lymphocytes and tumour‐associated stroma predict disease‐specific survival in triple‐negative breast cancer
inferred← citeshttps://doi.org/10.1002/tox.24317openalex-snapshot
Impact of anesthesia‐related genes on prognosis and tumor microenvironment in hepatocellular carcinoma: A comprehensive analysis
inferred← citeshttps://doi.org/10.1007/16833_2022_104openalex-snapshot
Histaminergic System as a Promising Target for Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-98950-7_13openalex-snapshot
Tumor Infiltrating Lymphocytes in Breast Cancer: Implementation of a New Histopathological Biomarker
inferred← citeshttps://doi.org/10.1007/978-3-031-33602-7_10openalex-snapshot
Innovative Therapeutic Approaches for Patients with HER2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.1007/s00210-025-04057-3openalex-snapshot
Mapping molecular landscapes in triple-negative breast cancer: insights from spatial transcriptomics
inferred← citeshttps://doi.org/10.1007/s00262-023-03584-3openalex-snapshot
Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer
inferred← citeshttps://doi.org/10.1007/s00428-025-04039-zopenalex-snapshot
The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review
inferred← citeshttps://doi.org/10.1007/s00432-023-04685-3openalex-snapshot
Targeting adipocyte–immune cell crosstalk to control breast cancer progression
inferred← citeshttps://doi.org/10.1007/s00432-023-05532-1openalex-snapshot
Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration
inferred← citeshttps://doi.org/10.1007/s10142-025-01646-6openalex-snapshot
Integrated multi-omics analysis of UL16-binding protein 2 as a prognostic and immunotherapy biomarker for colorectal cancer
inferred← citeshttps://doi.org/10.1007/s10549-021-06431-0openalex-snapshot
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
inferred← citeshttps://doi.org/10.1007/s10549-022-06575-7openalex-snapshot
Clinical trial data and emerging strategies: HER2-positive breast cancer
inferred← citeshttps://doi.org/10.1007/s10549-026-07928-2openalex-snapshot
Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII)
inferred← citeshttps://doi.org/10.1007/s11033-023-09134-5openalex-snapshot
Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines
inferred← citeshttps://doi.org/10.1007/s12032-025-02770-wopenalex-snapshot
Application of mass cytometry in the immune microenvironment of breast cancer
inferred← citeshttps://doi.org/10.1007/s12038-023-00386-8openalex-snapshot
Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer
inferred← citeshttps://doi.org/10.1007/s12094-023-03080-1openalex-snapshot
The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s12094-024-03641-yopenalex-snapshot
Characterization of SUSD3 as a novel prognostic biomarker and therapeutic target for breast cancer
inferred← citeshttps://doi.org/10.1007/s12282-021-01326-wopenalex-snapshot
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1007/s12672-024-01326-0openalex-snapshot
EBNA1BP2 identified as potential prognostic biomarker for multiple tumor types in pan-cancer analysis
inferred← citeshttps://doi.org/10.1007/s12672-025-01767-1openalex-snapshot
Integrated bioinformatics and experimental analysis of CHAF1B as a novel biomarker and immunotherapy target in LUAD
inferred← citeshttps://doi.org/10.1007/s12672-025-01963-zopenalex-snapshot
Mendelian randomization study identifying immune cell phenotypes associated with breast cancer risk
inferred← citeshttps://doi.org/10.1007/s12672-025-02393-7openalex-snapshot
Synergistic bioinformatics and sophisticated machine learning unveil ferroptosis-driven regulatory pathways and immunotherapy potential in breast carcinoma
inferred← citeshttps://doi.org/10.1007/s12672-025-03859-4openalex-snapshot
Integrated bioinformatics analysis to elucidate cellular communication in the microenvironment of breast cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-33349-1.00007-7openalex-snapshot
Advanced strategies for targeting severe triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.breast.2025.103889openalex-snapshot
Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
inferred← citeshttps://doi.org/10.1016/j.breast.2025.104545openalex-snapshot
Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancer
inferred← citeshttps://doi.org/10.1016/j.carbpol.2022.119689openalex-snapshot
Sodium alginate based drug delivery in management of breast cancer
inferred← citeshttps://doi.org/10.1016/j.clbc.2024.09.016openalex-snapshot
The Systemic Immune-Inflammation Index is a Predictor of Chemotherapy Sensitivity and Disease-Free Survival in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.cson.2023.100027openalex-snapshot
COL8A1 is a prognostic-related biomarker and correlated with immune infiltration in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2021.102222openalex-snapshot
Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2022.102462openalex-snapshot
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.05.018openalex-snapshot
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial
inferred← citeshttps://doi.org/10.1016/j.ejca.2023.113399openalex-snapshot
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177561openalex-snapshot
The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions
inferred← citeshttps://doi.org/10.1016/j.esmoop.2025.105095openalex-snapshot
Multi-assistant methods improve stromal tumor-infiltrating lymphocytes (sTILs) assessment in breast cancer: results of multi-institutional ring studies
inferred← citeshttps://doi.org/10.1016/j.genrep.2025.102396openalex-snapshot
PGK1 is a prognostic molecule and silencing PGK1 inhibits the growth in breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e23930openalex-snapshot
In-depth analysis of prognostic markers associated with the tumor immune microenvironment and genetic mutations in breast cancer based on an NK cell-related risk model
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29551openalex-snapshot
Identification of exosome-related gene signature as a promising diagnostic and therapeutic tool for breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.134393openalex-snapshot
RETRACTED: Research on the shared function of central neurons and breast cancer based on gene expression profile data mining: The role of EMID1 protein antibody expression
inferred← citeshttps://doi.org/10.1016/j.insi.2026.100304openalex-snapshot
Transcriptomic profiling of breast cancer subtypes identifies “FANCE” as universal and subtype-specific biomarkers
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.111026openalex-snapshot
Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in triple-negative breast cancer (TNBC)
inferred← citeshttps://doi.org/10.1016/j.jncc.2024.01.004openalex-snapshot
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy
inferred← citeshttps://doi.org/10.1016/j.microc.2025.116114openalex-snapshot
Exploring lipotoxicity-related prognostic genes and experimental validation in breast cancer using electrochemical sensors and single-cell transcriptomics analysis
inferred← citeshttps://doi.org/10.1016/j.modpat.2024.100650openalex-snapshot
Stromal Tumor-Infiltrating Lymphocytes in Hormone Receptor–Positive/HER2 Negative Metastatic Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.modpat.2025.100718openalex-snapshot
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline Benefit
inferred← citeshttps://doi.org/10.1016/j.neo.2025.101190openalex-snapshot
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling
inferred← citeshttps://doi.org/10.1016/j.pacs.2024.100653openalex-snapshot
Machine learning radiomics based on intra and peri tumor PA/US images distinguish between luminal and non-luminal tumors in breast cancers
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106926openalex-snapshot
The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo
inferred← citeshttps://doi.org/10.1016/j.senol.2022.04.005openalex-snapshot
Tratamiento neoadyuvante en el cáncer de mama. El papel del patólogo
inferred← citeshttps://doi.org/10.1038/s41416-022-02050-8openalex-snapshot
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
inferred← citeshttps://doi.org/10.1038/s41417-022-00473-2openalex-snapshot
Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis
inferred← citeshttps://doi.org/10.1038/s41417-026-01070-3openalex-snapshot
Advanced gene editing technologies for oncology mechanisms, applications, and clinical implementation
inferred← citeshttps://doi.org/10.1038/s41523-023-00527-0openalex-snapshot
The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
inferred← citeshttps://doi.org/10.1038/s41590-021-00961-xopenalex-snapshot
“Mind the GAP”: RGS1 hinders antitumor lymphocytes
inferred← citeshttps://doi.org/10.1038/s41598-022-09671-2openalex-snapshot
Spatial frequency domain imaging for monitoring immune-mediated chemotherapy treatment response and resistance in a murine breast cancer model
inferred← citeshttps://doi.org/10.1038/s41598-023-36517-2openalex-snapshot
Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-023-42434-1openalex-snapshot
RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-024-54670-0openalex-snapshot
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association
inferred← citeshttps://doi.org/10.1038/s41598-024-54888-yopenalex-snapshot
Neutrophil extracellular trap-associated risk index for predicting outcomes and response to Wnt signaling inhibitors in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-024-60581-xopenalex-snapshot
Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers
inferred← citeshttps://doi.org/10.1038/s41598-024-70184-1openalex-snapshot
Identification of the novel exhausted T cell CD8 + markers in breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-025-95703-6openalex-snapshot
Identification of potential shared gene signatures between periodontitis and breast cancer by integrating bulk RNA-seq and scRNA-seq data
inferred← citeshttps://doi.org/10.1080/07357907.2026.2725033openalex-snapshot
Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review
inferred← citeshttps://doi.org/10.1080/10286020.2024.2311149openalex-snapshot
Exploring the mechanism of daphne-type diterpenes against gastric cancer cells
inferred← citeshttps://doi.org/10.1080/1061186x.2023.2245579openalex-snapshot
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1080/13543784.2022.2054326openalex-snapshot
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
inferred← citeshttps://doi.org/10.1080/1354750x.2025.2591717openalex-snapshot
Emerging biomarkers in breast cancer: translational and multi-omics perspectives in precision oncology
inferred← citeshttps://doi.org/10.1080/19490976.2026.2697600openalex-snapshot
Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment
inferred← citeshttps://doi.org/10.1080/2162402x.2025.2610535openalex-snapshot
Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes
inferred← citeshttps://doi.org/10.1093/bjr/tqae129openalex-snapshot
Deep learning–based and BI-RADS guided radiomics model for tumour-infiltrating lymphocytes evaluation in breast cancer
inferred← citeshttps://doi.org/10.1093/carcin/bgad042openalex-snapshot
ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop
inferred← citeshttps://doi.org/10.1093/jjco/hyae033openalex-snapshot
Emerging measurements for tumor-infiltrating lymphocytes in breast cancer
inferred← citeshttps://doi.org/10.1093/jnci/djae178openalex-snapshot
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer
inferred← citeshttps://doi.org/10.1097/cej.0000000000000804openalex-snapshot
Computational pathology to improve biomarker testing in breast cancer: how close are we?
inferred← citeshttps://doi.org/10.1097/md.0000000000036315openalex-snapshot
Peripheral blood inflammatory indexes in breast cancer: A review
inferred← citeshttps://doi.org/10.1097/md.0000000000037654openalex-snapshot
Exploring neutrophil functionality in breast cancer progression: A review
inferred← citeshttps://doi.org/10.1097/pai.0000000000001125openalex-snapshot
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type
inferred← citeshttps://doi.org/10.1097/sla.0000000000005954openalex-snapshot
Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer
inferred← citeshttps://doi.org/10.1111/jcmm.70172openalex-snapshot
EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy
inferred← citeshttps://doi.org/10.1145/3608164.3608179openalex-snapshot
NDUFAF6 Promotes Breast Cancer Development as a Novel Marker for Diagnosis
inferred← citeshttps://doi.org/10.1148/ryai.250760openalex-snapshot
Radiopathomic Graph Deep Learning for Multiscale Spatial-Contextual Modeling of Intratumoral Heterogeneity to Predict Breast Cancer Response to Neoadjuvant Therapy
inferred← citeshttps://doi.org/10.1155/2023/3914687openalex-snapshot
CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR
inferred← citeshttps://doi.org/10.1155/2024/1373659openalex-snapshot
Mitochondria‐Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan‐Cancer Multiomics Analysis to Breast Cancer Validation
inferred← citeshttps://doi.org/10.1155/humu/8673018openalex-snapshot
Integrative Genomic Analysis Identifies MAGT1 as a Key Regulator of Proliferation and Poor Prognosis in Breast Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6533188.v1openalex-snapshot
Data from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6760515.v1openalex-snapshot
Data from A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-22-1587openalex-snapshot
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-23-0480openalex-snapshot
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer
inferred← citeshttps://doi.org/10.1172/jci.insight.199927openalex-snapshot
Activating mutations in ESR1 contribute to an immunosuppressive breast tumor microenvironment by dampening cytokine secretion
inferred← citeshttps://doi.org/10.1177/15347354251349824openalex-snapshot
Progress of Traditional Chinese Medicine in Regulating Immune Cell in the Tumor Microenvironment of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1186/s12880-026-02308-0openalex-snapshot
Evaluating the predictive value of dynamic contrast-enhanced MRI and six diffusion models for prognostic factors in mass-type invasive ductal carcinoma of the breast
inferred← citeshttps://doi.org/10.1186/s12885-023-11411-2openalex-snapshot
High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer
inferred← citeshttps://doi.org/10.1186/s12885-025-13875-wopenalex-snapshot
Causal association of breast cancer with immune cells: new evidence from bi-directional Mendelian randomization using GWAS summary statistics
inferred← citeshttps://doi.org/10.1186/s12885-026-15795-9openalex-snapshot
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer
inferred← citeshttps://doi.org/10.1186/s12935-025-03635-yopenalex-snapshot
Characterizing tertiary lymphoid structures associated single-cell atlas in breast cancer patients
inferred← citeshttps://doi.org/10.1186/s12943-026-02655-0openalex-snapshot
Breast cancer immunotherapy: mechanisms of immune evasion, biomarkers, and emerging therapeutic strategies
inferred← citeshttps://doi.org/10.1186/s12957-021-02387-zopenalex-snapshot
Comprehensive analysis of the cancer driver genes in breast cancer demonstrates their roles in cancer prognosis and tumor microenvironment
inferred← citeshttps://doi.org/10.1186/s13000-022-01278-5openalex-snapshot
Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar
inferred← citeshttps://doi.org/10.1186/s13046-026-03709-3openalex-snapshot
Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer
inferred← citeshttps://doi.org/10.1186/s13058-024-01928-0openalex-snapshot
Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study
inferred← citeshttps://doi.org/10.1186/s13058-026-02285-wopenalex-snapshot
Tumor-infiltrating lymphocytes in triple-negative breast cancer: molecular mechanisms, spatial regulation, and therapeutic implications
inferred← citeshttps://doi.org/10.1186/s13062-022-00342-wopenalex-snapshot
Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
inferred← citeshttps://doi.org/10.1186/s40001-024-02010-3openalex-snapshot
CYB561 is a potential therapeutic target for breast cancer and is associated with immune cell infiltration
inferred← citeshttps://doi.org/10.1186/s42234-025-00173-wopenalex-snapshot
Revolutionizing breast cancer immunotherapy by integrating AI and nanotechnology approaches: review of current applications and future directions
inferred← citeshttps://doi.org/10.1200/jco.22.02375openalex-snapshot
POLARized Risk for Local Recurrence on the Basis of Tumor Biology: Is It That Simple?
inferred← citeshttps://doi.org/10.1200/po-25-00349openalex-snapshot
Single-Cell Immune Signature and Response to Neoadjuvant Chemotherapy in BRCA1/2 -Mutated Breast Cancer
inferred← citeshttps://doi.org/10.1245/s10434-024-16454-8openalex-snapshot
Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials
inferred← citeshttps://doi.org/10.12659/msm.938512openalex-snapshot
EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.12677/acm.2022.1281062openalex-snapshot
Research on the Correlation between TILs and Neoadjuvant Efficacy in Breast Cancer
inferred← citeshttps://doi.org/10.12968/hmed.2024.0809openalex-snapshot
Comparative Evaluation of Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiotherapy in Postoperative Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1371/journal.pone.0304194openalex-snapshot
Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer
inferred← citeshttps://doi.org/10.1371/journal.pone.0314450openalex-snapshot
An interpretable framework for inter-observer agreement measurements in TILs scoring on histopathological breast images: A proof-of-principle study
inferred← citeshttps://doi.org/10.1371/journal.pone.0342085openalex-snapshot
Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis
inferred← citeshttps://doi.org/10.14814/phy2.70649openalex-snapshot
Interactions among tumor subtype, PPARγ expression, and adipose proliferation shape outcomes in breast cancer
inferred← citeshttps://doi.org/10.1515/biol-2022-1001openalex-snapshot
Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
inferred← citeshttps://doi.org/10.1515/cclm-2023-1056openalex-snapshot
Specifications of qPCR based epigenetic immune cell quantification
inferred← citeshttps://doi.org/10.1515/med-2022-0547openalex-snapshot
Oncogenic role of TWF2 in human tumors: A pan-cancer analysis
inferred← citeshttps://doi.org/10.1615/critrevimmunol.2023050829openalex-snapshot
Integrated Bioinformatics Analysis to Identify a Novel Four-Gene Prognostic Model of Breast Cancer and Reveal Its Association with Immune Infiltration
inferred← citeshttps://doi.org/10.17650/2313-805x-2026-13-1-16-29openalex-snapshot
Local and systemic immune profiles in tumors
inferred← citeshttps://doi.org/10.18632/aging.205003openalex-snapshot
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
inferred← citeshttps://doi.org/10.20944/preprints202306.1524.v1openalex-snapshot
Biological and Clinical Significance of TIMPs Expression in Breast Cancer: a Bioinformatic Analysis
inferred← citeshttps://doi.org/10.20944/preprints202310.0190.v1openalex-snapshot
Epithelial-Mesenchymal Transition in Tumor Cells and Activated Intra-Tumor Immunity Respectively Are Correlated With Prognosis and Chemo-Sensitivity in Breast Cancer Patients With a Non-pathological Response to Neoadjuvant Chemotherapy
inferred← citeshttps://doi.org/10.21037/tcr-24-1829openalex-snapshot
Establishment and verification of a prognostic immune cell signature-based model for breast cancer overall survival
inferred← citeshttps://doi.org/10.21203/rs.3.rs-10826372/v1openalex-snapshot
p140Cap guides personalized combination strategies with anti-PD-L1 immunotherapy in HER2+ and triple-negative breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1818356/v1openalex-snapshot
Effects of low tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2854482/v1openalex-snapshot
A seven-Lnc RNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3327808/v1openalex-snapshot
CYB561 is a potential therapeutic target for BC and is associated with immune cell infiltration
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3362960/v1openalex-snapshot
Identification novel Necroptosis-related LncRNAs to predict prognosis and screen the population benefiting from anti-PD-1/PDL-1 treatment in breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3579602/v1openalex-snapshot
Combining glycolysis and oxidative stress characterizations to assess prognosis in ovarian cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-9517242/v1openalex-snapshot
Prognostic Prediction, Immune Landscape, and Drug Sensitivity Based on Apical Junction Complex-Related Genes and Machine Learning in Endometrial Cancer Short title: Apical Junction Complex-Related Genes Endometrial Cancer
inferred← citeshttps://doi.org/10.2147/bctt.s400055openalex-snapshot
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
inferred← citeshttps://doi.org/10.2147/bctt.s546371openalex-snapshot
Common Biomarkers and Pathogenesis of Inflammatory Bowel Disease and Breast Cancer: Mendelian Randomization and Multi-Omics Studies
inferred← citeshttps://doi.org/10.2147/bctt.s575936openalex-snapshot
Emerging Targeted and Multimodal Therapeutic Strategies in Breast Cancer: A Comprehensive Review
inferred← citeshttps://doi.org/10.2147/ijgm.s470303openalex-snapshot
Upregulation of ZMAT3 is Associated with the Poor Prognosis of Breast Cancer
inferred← citeshttps://doi.org/10.2174/0115748928258157231128103337openalex-snapshot
Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment
inferred← citeshttps://doi.org/10.21873/anticanres.15131openalex-snapshot
PD-L1 Expression, T-lymphocyte Subpopulations and Langerhans Cells in Cutaneous Squamous Cell Carcinoma and Precursor Lesions
inferred← citeshttps://doi.org/10.21873/invivo.12578openalex-snapshot
Modulation of Immune System – Strategy in the Treatment of Breast Cancer
inferred← citeshttps://doi.org/10.2217/imt-2022-0277openalex-snapshot
Current and Future Trends in Neoadjuvant Immunotherapy for the Treatment of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.26420/austinjsurg.2021.1270openalex-snapshot
Immune Check-Point Inhibitors in Breast Cancer: Current Evidence and Future Directions
inferred← citeshttps://doi.org/10.31083/j.fbl2902073openalex-snapshot
The Role of CD8A in the Immune Microenvironment of Breast Cancer
inferred← citeshttps://doi.org/10.31557/apjcp.2022.23.10.3331openalex-snapshot
Association between PIK3CA Mutations in Blood and Tumor-Infiltrating Lymphocytes in Peruvian Breast Cancer Patients
inferred← citeshttps://doi.org/10.31557/apjcp.2022.23.3.1061openalex-snapshot
The Role of Beetroot Extract in Overcoming Chemoresistance of Neoadjuvant Adriamycin Cyclophosphamide Regimen by Targeting Immune Response in Tumor Microenvironment: A Preclinical Study in Mammary Adenocarcinoma Rats
inferred← citeshttps://doi.org/10.32948/ajo.2024.04.06openalex-snapshot
Progress in research and treatment of immune checkpoints in breast cancer
inferred← citeshttps://doi.org/10.3389/fcell.2024.1421629openalex-snapshot
Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
inferred← citeshttps://doi.org/10.3389/fendo.2023.1256132openalex-snapshot
Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment
inferred← citeshttps://doi.org/10.3389/fgene.2022.1010787openalex-snapshot
An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
inferred← citeshttps://doi.org/10.3389/fgene.2022.888672openalex-snapshot
NcRNA-mediated upregulation of CAMK2N1 is associated with poor prognosis and tumor immune infiltration of gastric cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2021.751530openalex-snapshot
From Cellular Infiltration Assessment to a Functional Gene Set-Based Prognostic Model for Breast Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2022.982486openalex-snapshot
The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1145080openalex-snapshot
Copper-related genes predict prognosis and characteristics of breast cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1258641openalex-snapshot
The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1550003openalex-snapshot
Tumor-infiltrating immune cells state-implications for various breast cancer subtypes
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1590951openalex-snapshot
Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1851289openalex-snapshot
Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1
inferred← citeshttps://doi.org/10.3389/fonc.2021.692136openalex-snapshot
A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors
inferred← citeshttps://doi.org/10.3389/fonc.2021.734959openalex-snapshot
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
inferred← citeshttps://doi.org/10.3389/fonc.2021.773078openalex-snapshot
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
inferred← citeshttps://doi.org/10.3389/fonc.2022.1022542openalex-snapshot
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
inferred← citeshttps://doi.org/10.3389/fonc.2023.1182725openalex-snapshot
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients
inferred← citeshttps://doi.org/10.3389/fonc.2024.1350935openalex-snapshot
Patient-derived organoids: a promising tool for breast cancer research
inferred← citeshttps://doi.org/10.3389/fonc.2024.1382701openalex-snapshot
Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer
inferred← citeshttps://doi.org/10.3389/fonc.2025.1511564openalex-snapshot
A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
inferred← citeshttps://doi.org/10.3389/fphar.2022.883998openalex-snapshot
Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis
inferred← citeshttps://doi.org/10.3389/pore.2023.1610956openalex-snapshot
NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
inferred← citeshttps://doi.org/10.3390/biom15091318openalex-snapshot
Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity
inferred← citeshttps://doi.org/10.3390/biomedicines11112889openalex-snapshot
HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration
inferred← citeshttps://doi.org/10.3390/cancers13194756openalex-snapshot
Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers13235999openalex-snapshot
Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives
inferred← citeshttps://doi.org/10.3390/cancers14030591openalex-snapshot
Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers14143305openalex-snapshot
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers14184505openalex-snapshot
Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood
inferred← citeshttps://doi.org/10.3390/cancers14194885openalex-snapshot
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers14246034openalex-snapshot
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers15030597openalex-snapshot
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
inferred← citeshttps://doi.org/10.3390/cancers15030838openalex-snapshot
Deep Learning with Transformer or Convolutional Neural Network in the Assessment of Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Based on US Images: A Dual-Center Retrospective Study
inferred← citeshttps://doi.org/10.3390/cancers15051517openalex-snapshot
B Cells in Breast Cancer Pathology
inferred← citeshttps://doi.org/10.3390/cancers15092615openalex-snapshot
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
inferred← citeshttps://doi.org/10.3390/cancers15102773openalex-snapshot
LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers15204932openalex-snapshot
Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis
inferred← citeshttps://doi.org/10.3390/cancers15245773openalex-snapshot
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness
inferred← citeshttps://doi.org/10.3390/cancers16030634openalex-snapshot
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers16091626openalex-snapshot
Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types
inferred← citeshttps://doi.org/10.3390/cancers17081363openalex-snapshot
Inflammation and Thyroid Cancer: Deciphering the Role of Blood Immune Indexes
inferred← citeshttps://doi.org/10.3390/cancers17244010openalex-snapshot
PAM50 Intrinsic Subtypes and Immunity Status in Prognosis of Triple-Negative Breast Cancer: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.3390/cells11050885openalex-snapshot
A Coculture Model Mimicking the Tumor Microenvironment Unveils Mutual Interactions between Immune Cell Subtypes and the Human Seminoma Cell Line TCam-2
inferred← citeshttps://doi.org/10.3390/cells11162578openalex-snapshot
The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications
inferred← citeshttps://doi.org/10.3390/diagnostics12102527openalex-snapshot
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
inferred← citeshttps://doi.org/10.3390/genes13101838openalex-snapshot
A Comprehensive Analysis of KRT19 Combined with Immune Infiltration to Predict Breast Cancer Prognosis
inferred← citeshttps://doi.org/10.3390/genes16020160openalex-snapshot
Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation
inferred← citeshttps://doi.org/10.3390/ijms232113322openalex-snapshot
A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
showing the first 200 of 228 · page through all 228
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.